Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Mallinckrodt_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:countryOfOrigin |
gptkb:United_States
|
| gptkbp:focusesOn |
neurology
rare diseases gastrointestinal disorders |
| gptkbp:foundedBy |
Ryuji Ueno
Sachiko Kuno |
| gptkbp:foundedYear |
1996
|
| gptkbp:headquartersLocation |
gptkb:Bethesda,_Maryland,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sucampo Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Amitiza
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:SCMP
|
| gptkbp:bfsParent |
gptkb:Peter_Greenleaf
|
| gptkbp:bfsLayer |
8
|